Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Pharmacology, Biochemistry, and Behavior|February 1, 1981
A technique for chronic jugular catheterization in the ferretA P Florczyk, J E SchurigCancer Treatment Reports|January 1, 1982
Cisplatin-induced emesis in the Ferret: a new animal modelA P Florczyk, J E Schurig, W T BradnerCancer Chemotherapy and Pharmacology|January 1, 1986
The mouse as a model for predicting the myelosuppressive effects of anticancer drugsJ E Schurig, A P Florczyk, W T BradnerInvestigational New Drugs|January 1, 1990
Antitumor activity and toxicity in animals of N-7[2-(4-nitrophenyldithio) ethyl] mitomycin C (BMY-25067)W T Bradner, W C Rose, J E Schurig, et al.Cancer Treatment Reports|October 1, 1982
Antiemetic activity of butorphanol against cisplatin-induced emesis in ferrets and dogsJ E Schurig, A P Florczyk, W C Rose, et al.Experimental Hematology|January 1, 1985
Animal models for evaluating the myelosuppressive effects of cancer chemotherapeutic agentsJ E Schurig, A Schlein, A P Florczyk, et al.Cancer Research|December 1, 1985
Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivativeW T Bradner, W C Rose, J E Schurig, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Tallysomycin S10b: experimental antitumor activity and toxicityJ E Schurig, W C Rose, R S Hirth, et al.Cancer Treatment Reports|November 1, 1979
Pharmacokinetics of tallysomycin and bleomycin in the beagle dogJ E Strong, J E Schurig, B F Issell, et al.Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacokinetics of carminomycin in dogs and humans. Preliminary reportS D Reich, S E Fandrich, T T Finkelstein, et al.Pageof 4